Tellgen Corporation

Shenzhen Stock Exchange 300642.SZ

Tellgen Corporation Total Non-Current Liabilities for the year ending December 31, 2023: USD 1.78 M

Tellgen Corporation Total Non-Current Liabilities is USD 1.78 M for the year ending December 31, 2023, a -22.36% change year over year. Total non-current liabilities are the sum of long-term debt and other non-current liabilities.
  • Tellgen Corporation Total Non-Current Liabilities for the year ending December 31, 2022 was USD 2.30 M, a -30.94% change year over year.
  • Tellgen Corporation Total Non-Current Liabilities for the year ending December 31, 2021 was USD 3.33 M, a 114.41% change year over year.
  • Tellgen Corporation Total Non-Current Liabilities for the year ending December 31, 2020 was USD 1.55 M, a 45.90% change year over year.
  • Tellgen Corporation Total Non-Current Liabilities for the year ending December 31, 2019 was USD 1.06 M, a -1.24% change year over year.
Key data
Date Total Non-Current Liabilities Shareholders' Equity Other Liabilities Total Liabilities
Market news
SV Wall Street
Shenzhen Stock Exchange: 300642.SZ

Tellgen Corporation

CEO Mr. Jian Er Yao
IPO Date April 21, 2017
Location China
Headquarters Building 1
Employees 574
Sector Healthcare
Industries
Biotechnology 3D Printing Cleaning Supplies Cosmetics Glass Personal Care Pharmaceuticals Vaccines
Description

Tellgen Corporation researches and develops, manufactures, and distributes IVDs in China and internationally. It offers tumor markers, human papilloma virus test kits, ToRCH products, Y chromosome microdeletions test kits, and multiplex immunoassay systems. The company was founded in 2003 and is based in Shanghai, China.

StockViz Staff

February 2, 2025

Any question? Send us an email